OUTCOME OF BOARD MEETING
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Symbiox Investment & Trading Co. Ltd met on August 6, 2025 and approved the unaudited financial results for the quarter ended June 30, 2025 (Q1 FY26). Revenue from operations rose to ₹45.81 lakh from ₹31.23 lakh in the same quarter last year, a jump of nearly 47%. Total income stood at ₹46.00 lakh versus ₹31.23 lakh YoY. Profit before tax surged to ₹9.04 lakh from just ₹0.75 lakh, and profit after tax came in at ₹6.69 lakh versus ₹0.56 lakh in Q1 FY25 – roughly a 12-fold increase. Basic EPS improved to ₹0.021 from ₹0.002. The statutory auditor (SSR V & Associates) issued an unqualified limited review report on the results.
The strong YoY turnaround in both revenue and profit is a positive signal for shareholders, though the absolute numbers remain very small (revenue under ₹50 lakh) and the stock is thinly traded on BSE/CSE. Investors should note that FY25 ended with a quarterly loss in Q4 (₹29.94 lakh), so the Q1 FY26 rebound, while encouraging, needs to be sustained over coming quarters to be meaningful for the stock price.